Results 131 to 140 of about 2,445,433 (252)

Aerospace medicine and biology: A continuing bibliography with indexes (supplement 309) [PDF]

open access: yes
This bibliography lists 136 reports, articles and other documents introduced into the NASA scientific and technical information system in February ...

core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

The writing of scientific articles

open access: yesBrazilian Journal of Otorhinolaryngology, 2014
Mauricio Gomes Pereira
doaj   +1 more source

Aerospace medicine and biology: A continuing bibliography with indexes, supplement 218, April 1981 [PDF]

open access: yes
This bibliography lists 161 reports, articles, and other documents introduced into the NASA scientific and technical information system in March ...

core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

COVID-19 Study on Scientific Articles in Health Communication: A Science Mapping Analysis in Web of Science. [PDF]

open access: yesInt J Environ Res Public Health, 2022
de Las Heras-Pedrosa C   +3 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

open access: yesMolecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy